Oral bioavailability of dabigatran etexilate (Pradaxa®) after co-medication with verapamil in healthy subjects
Author:
Affiliation:
1. Boehringer Ingelheim Pharma GmbH; Biberach; Germany
2. Boehringer Ingelheim Pharmaceuticals; Ridgefield; CT; USA
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2012.04453.x/fullpdf
Reference23 articles.
1. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009
2. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial;Eriksson;J Thromb Haemost,2007
3. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial;Eriksson;Lancet,2007
4. Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial;Paikin;Expert Rev Cardiovasc Ther,2011
5. FDA Pradaxa label 2010 http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022512s007lbl.pdf
Cited by 141 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The pharmacokinetics of dabigatran in a rat model of hyperlipidemia induced by poloxamer 407;Xenobiotica;2024-09-12
2. Cassia angustifolia and tacrolimus interaction in a liver transplant patient, a case report;British Journal of Clinical Pharmacology;2024-04-24
3. Assessing the relative contribution of CYP3A-and P-gp-mediated pathways to the overall disposition and drug-drug interaction of dabigatran etexilate using a comprehensive mechanistic physiological-based pharmacokinetic model;Frontiers in Pharmacology;2024-03-07
4. Anticoagulation in Patients with Chronic Kidney Disease;American Journal of Nephrology;2023-11-30
5. ABC Transporters in Intestinal and Liver Efflux;Oral Bioavailability and Drug Delivery;2023-10-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3